CLINICAL_TRIALS
research
· 2010-04-28
Clinical Trial Update: Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis [Phase 2]
Summary
A Phase 2 trial comparing hypertonic saline 6% with isotonic saline 0.9% in bronchiectasis; current status of the trial is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Belfast Health and Social Care Trust | Conditions: Bronchiectasis | Phase 2 | Status: UNKNOWN